What is Cytomegalovirus?
Cytomegalovirus (sy-toe-MEG-a-low-vy-rus) (CMV) is a common virus that’s undoubtedly a tongue-twister. Even with a name that’s 15 letters long, many people know little about it. The majority of individuals who contract CMV are not aware they have it. Unfortunately, lack of awareness isn’t a positive thing in this case. Cytomegalovirus has a more nefarious side that preys on the most vulnerable populations. Through education and research, we are ending the commonality of CMV.
What is CMV, and How Common is it?
The virus that causes human CMV infections belongs to the herpes virus family. Once an individual contracts CMV, it stays with them their entire life. Like other herpes viruses, it can remain dormant and then reactivate. Re-infection from another strain is also possible.
The Centers for Disease Control and Prevention (CDC) estimates that between 50 and 80 percent of people in the United States have had a CMV infection by the time they are 40 years old.
Symptoms and Vulnerable Population for Severe Disease
In most cases, individuals with a CMV infection don’t experience symptoms, thus making them unaware they have it. Mild symptoms generally consist of fatigue, fever, sore throat, and muscle aches. Below are the three main populations at risk for severe CMV symptoms and complications:
- Congenital CMV: When an infant gets a CMV infection before birth.
- Severe symptoms include jaundice, fever, and enlargement of the spleen and liver.
- Perinatal CMV: When a baby is infected with CMV during or shortly after birth.
- Infants that contract CMV after birth can face deafness, blindness, and other long-term neurological complications such as intellectual disabilities.
- CMV infection individuals with weakened immune systems:
- Severe symptoms include advanced pneumonia and inflammation of the retina that can lead to blindness. Stomach and esophagus ulcers and infections in the brain can also occur.
Transmission and Prevention of CMV
Once CMV infection occurs, the virus can also pass into body fluids, such as saliva, urine, blood, tears, semen, and breast milk. Therefore, individuals with CMV can spread it to others in the following ways:
- From direct contact with saliva or urine, especially from babies and young children
- Through sexual contact
- Nursing infants from breastmilk
- Through transplanted organs and blood transfusions
In addition, pregnant women who have CMV can also pass the virus to their baby while still in the uterus or during birth. About 1 out of 200 babies is born with congenital CMV. Out of the babies infected, 1 in 5 will have symptoms or a long-term health problem that may be present at birth or develop after. As a result, CMV is the most common infectious cause of congenital disabilities in the U.S. Despite this, CMV is preventable. You can find general prevention tips and screening information for women of childbearing age and those currently pregnant on the National CMV Foundation website.
Antiviral medications are the traditional form of treatment because they can slow the spread of the virus. Even though none of the available therapies can eliminate the CMV virus, researchers are studying potential new options to treat and prevent it. ActivMed Practices & Research is looking for healthy women to join our CMV vaccine studies at our Methuen, MA location.
Apply today via our website or contact us at (978) 655-7155.
Sources:
https://www.nationalcmv.org/overview/start-here
- Blog (139)
- Alzheimer's Disease (18)
- Atopic Dermatitis (4)
- Alzheimers Clinical Trials (2)
- Charity Event (2)
- Chronic Conditions (2)
- #CTD2020 (1)
- 2019 (1)
- Acne (1)
- Adolescent (1)
- Advice (1)
- Age Friendly (1)
- Alzheimer's Agitation (1)
- Alzheimer's Research (1)
- Alzheimer's and Brain Awareness Month (1)
- Alzheimers Study (1)
- American Heart Association (1)
- American Heart Month (1)
- American Stroke Month (1)
- Annual (1)
- Article (1)
- Atopic Dermatitis Care (1)
- Baseline Memory Screen (1)
- Binge Eating (1)
- Blood Pressure (1)
- Brain Health (1)
- Caregiver (1)
- Chronic Pain (1)
- April 2022 (2)
- March 2022 (2)
- February 2022 (2)
- January 2022 (2)
- December 2021 (2)
- November 2021 (2)
- October 2021 (2)
- September 2021 (2)
- August 2021 (3)
- July 2021 (2)
- June 2021 (1)
- May 2021 (1)
- April 2021 (2)
- March 2021 (2)
- February 2021 (3)
- January 2021 (2)
- December 2020 (2)
- November 2020 (3)
- October 2020 (2)
- September 2020 (3)
- August 2020 (4)
- July 2020 (3)
- June 2020 (3)
- May 2020 (5)
- April 2020 (2)
- March 2020 (6)
- February 2020 (2)
- January 2020 (4)
- December 2019 (3)
- November 2019 (5)
- October 2019 (8)
- September 2019 (3)
- August 2019 (3)
- July 2019 (3)
- June 2019 (5)
- May 2019 (6)
- April 2019 (5)
- March 2019 (3)
- February 2019 (2)
- January 2019 (2)
- December 2018 (4)
- November 2018 (3)
- October 2018 (5)
- September 2018 (5)
- August 2018 (8)
- July 2018 (6)
- June 2018 (5)
- May 2018 (4)
- April 2018 (6)
- March 2018 (4)
- February 2018 (1)
- January 2018 (2)
- December 2017 (2)
- November 2017 (4)
- October 2017 (1)
- September 2017 (1)
- August 2017 (2)
- July 2017 (1)
- May 2017 (2)
- April 2017 (2)
- March 2017 (4)
- September 2016 (2)
- August 2016 (3)
- July 2016 (1)
- May 2016 (2)
- April 2016 (1)
- March 2016 (1)
- February 2016 (1)
- January 2016 (3)
- October 2014 (1)
